Skip to main content

Advertisement

SpringerLink
Log in

Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma

  • Letter to the Editor
  • Published:
Annals of Hematology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Barrington SF, Mikhaeel NG, Kostakoglu L, Meignan M, Hutchings M, Mueller SP, Schwartz LH, Zucca E, Fisher RI, Trotman J, Hoekstra OS, Hicks RJ, O’Doherty MJ, Hustinx R, Biggi A, Cheson BD (2014) Role of imaging in the staging and response assessment of lymphoma: consensus of the International Conference on Malignant Lymphomas Imaging Working Group. J Clin Oncol 32(27):3048–3058. doi:10.1200/JCO.2013.53.5229

    Article  PubMed  Google Scholar 

  2. Cheson BD, Fisher RI, Barrington SF, Cavalli F, Schwartz LH, Zucca E, Lister TA (2014) Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification. J Clin Oncol 32(27):3059–3068. doi:10.1200/JCO.2013.54.8800

    Article  PubMed  Google Scholar 

  3. Jamar F, Lhommel R (2015) Interim 18F-FDG-PET in diffuse large B-cell lymphoma: emerging worldwide? J Nucl Med. doi:10.2967/jnumed.114.151183

    Google Scholar 

  4. Meignan M, Gallamini A, Haioun C, Barrington S, Itti E, Luminari S, Polliack A (2015) Report on the 5 International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19–20 September 2014. Leuk Lymphoma:1–9. doi:10.3109/10428194.2015.1034707

  5. Sun N, Zhao J, Qiao W, Wang T (2015) Predictive value of interim PET/CT in DLBCL treated with R-CHOP: meta-analysis. Biomed Res Int 2015:648572. doi:10.1155/2015/648572

    PubMed Central  PubMed  Google Scholar 

  6. Adams HJ, Nievelstein RA, Kwee TC (2015) Prognostic value of complete remission status at end-of-treatment FDG-PET in R-CHOP-treated diffuse large B-cell lymphoma: systematic review and meta-analysis. Br J Haematol. doi:10.1111/bjh.13420

    Google Scholar 

Download references

Conflict of interest

The authors declare that they have no conflict of interest.

Funding

This work was financially supported by an Alpe d’HuZes/Dutch Cancer Society Bas Mulder Award for T.C.K. (grant number 5409). Data collection, data analysis, interpretation of data, writing of the paper, and decision to submit were left to the authors’ discretion and were not influenced by Alpe d’HuZes/Dutch Cancer Society.

Author information

Authors and Affiliations

  1. Department of Radiology and Nuclear Medicine, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands

    Hugo J. A. Adams & Thomas C. Kwee

Authors
  1. Hugo J. A. Adams
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Thomas C. Kwee
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Hugo J. A. Adams.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Adams, H.J.A., Kwee, T.C. Evidence-based reflection on the value of FDG-PET for interim and end-of-treatment response assessment in diffuse large B-cell lymphoma. Ann Hematol 94, 1611–1613 (2015). https://doi.org/10.1007/s00277-015-2425-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00277-015-2425-9

Keywords

Search

Navigation